Further, KLF2 expression in humans is inversely associated with numerous inflammatory and metabolic disease metrics, such as TNFA expression, soluble C-reactive protein levels, body mass index (BMI), and hypertension (Supplementary Fig. 1A–F). Here, KLF2 is linked to metabolic disease.